Skip to main content
Clinical Trials/NCT01954771
NCT01954771
Completed
Not Applicable

A Prospective, Randomized, Controlled Study on Self-monitoring of Blood Glucose (SMBG) Protocols in Predicting Glucose Levels in Senior Patients With Type 2 Diabetes Mellitus (T2DM) and Coronary Artery Disease (CAD)

Beijing Anzhen Hospital1 site in 1 country89 target enrollmentJune 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Diabetes Mellitus, Type 2
Sponsor
Beijing Anzhen Hospital
Enrollment
89
Locations
1
Primary Endpoint
Evaluation of Peak and Nadir Glucose Profiles From Continuous Glucose Monitoring System (CGMS)
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

Self-monitoring of blood glucose (SMBG) is a common way to assess glycemic control in diabetes management. Multiple times of blood glucose measurements by fingerstick in the same day are of tough challenge to it. The changes and variations of glucose excursion in senior diabetics with Coronary Artery Disease (CAD)involve a safety issue besides glycated hemoglobin (GHb) value. The goal of this study is to explore modified SMBG protocols for precisely monitoring and predicting glycemic excursion, variability in senior type 2 diabetics with CAD.

Registry
clinicaltrials.gov
Start Date
June 2013
End Date
June 2016
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Beijing Anzhen Hospital
Responsible Party
Principal Investigator
Principal Investigator

Yingsheng Zhou, MD; PhD

Director of Endocrinology and Metabolism Department of Capital Medical University Affiliated Beijing Anzhen Hospital

Beijing Anzhen Hospital

Eligibility Criteria

Inclusion Criteria

  • Clinical diagnosis of type 2 diabetes
  • Clinical diagnosis of coronary artery disease
  • Age ≥65 years
  • The blood glucose is controlled by diets and (or) oral hypoglycemic drugs
  • BMI≤28 kg/m²
  • Being able to monitor and record capillary glucose value by themselves at home

Exclusion Criteria

  • Diabetic ketoacidosis (DKA)
  • Acute cardiovascular events
  • Insulin treatment
  • Incapable to perform SMBG at home

Outcomes

Primary Outcomes

Evaluation of Peak and Nadir Glucose Profiles From Continuous Glucose Monitoring System (CGMS)

Time Frame: 12 weeks

The peak value:\>16.7mmol/L(which may precipitate ketosis),nadir:≤2.8mmol/L(Severe hypoglycemia).

Secondary Outcomes

  • Number of Participants With Severe Hypoglycemia (≤50 mg/dL or 2.8mmol/L),Captured by SMBG Method and CGMS(12 weeks)
  • HbA1c(%) at Endpoint(12 weeks)
  • The Correlation Study Between HbA1c and Glycemic Profiles of MBG (Mean Blood Glucose) From SMBG Protocols and CGMS(12 weeks)

Study Sites (1)

Loading locations...

Similar Trials